P-033 YI Efficacy and Safety of Vedolizumab for Inflammatory Bowel Disease in Clinical Practice.

Chaudrey, Khadija; Lightner, Amy; Singh, Siddharth; More

Inflammatory Bowel Diseases . 22():S19-S20, March 2016.

P-099 Sex-Based Differences in Adverse Events of Crohn's Disease Patients Treated with Certolizumab Pegol: A Pooled Safety Analysis of 15 Studies.

Kane, Sunanda; Loftus, Edward Jr; Choudhary, Cuckoo; More

Inflammatory Bowel Diseases . 22():S40-S41, March 2016.